Colorectal cancer, also known as colon cancer, is one of the most common types of cancer in both men and women around the world. Once thought to be mainly a disease of older adults, it is now ...

A new study has found evidence linking the use of GLP-1 medications like Ozempic and Wegovy to lower death rates in colon cancer patients. The University of California, San Diego study examined data ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and Mounjaro) had substantially lower five-year death rates than those not using ...

In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took GLP-1 ...

Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment ...

New NCCN guidelines highlight how structured exercise and molecular profiling significantly reduce recurrence rates. Regular exercise is no longer just a recommendation for general health; it is now a ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A three-year exercise program improved ...

Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading cancer killer for ...

This article originally appeared on The Conversation. An increasing number of people are dying of colorectal cancer at a young age, including those as young as 20. Actor James Van Der Beek, who was ...

Renin-angiotensin system inhibitors (RASIs) are associated with improved survival outcomes in patients with stage II/III colon cancer and hypertension following surgery. In a matched cohort of 2292 ...